Literature DB >> 14531944

Pharmacokinetic-pharmacodynamic modeling of daurisoline and dauricine in beagle dogs.

Shao-Jun Shi1, Hui Chen, Shi-Fen Gu, Fan-Dian Zeng.   

Abstract

AIM: To study the combined pharmacokinetic-pharmacodynamic (PK-PD) model of daurisoline and dauricine, and compare their effects on cardiac electrophsiology, blood pressure, and hemodynamics in beagle dogs.
METHODS: The plasma drug concentration was determined by the reversed-phase HPLC method and the effects on cardiac and hemodynamics were recorded by polygraph. The pharmacokinetic and PK-PD model parameters were calculated.
RESULTS: The pharmacokinetics were best fitted to a two-compartment open model, and the relationship between effect and effect compartment concentration of both drugs could be represented by the sigmoid-E(max) model. There were no significant differences in main pharmacokinetics and PK-PD parameters between the two drugs.
CONCLUSION: No statistically different kinetic disposition characteristics and potencies of inhibitory effects on myocardial function of daurisoline and dauricine were found in beagle dogs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531944

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  2 in total

1.  Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions.

Authors:  Xiao-Hui Huang; Fu-Rong Qiu; Hai-Tang Xie; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

2.  PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions.

Authors:  Xiao-Hui Huang; Jun Li; Fu-Rong Qiu; Hai-Tang Xie; Ji-Han Huang; Jian-Chun Li; Qing-Shan Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.